Summary
Opportunities in the Abrysvo market are driven by unmet RSV vaccine needs, aging populations, rising RSV cases, and expanded adult immunization programs. Growth is supported by enhanced vaccine access, preventive care focus, and increasing healthcare expendit
Source: GlobeNewswire
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
